2017-03-15,Voyager Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results And Corporate Highlights
2017-03-08,Voyager Therapeutics To Host Fourth Quarter And Full Year 2016 Financial Results Conference Call
2017-02-28,Voyager Therapeutics Supports Rare Disease Day® And Global Movement To Raise Awareness For Rare Diseases
2017-02-13,Voyager Therapeutics Announces Lead Clinical Candidate Selection For Monogenic Form Of Amyotrophic Lateral Sclerosis (ALS)
2017-02-02,Voyager Therapeutics To Attend Upcoming Investor Conferences
2017-01-25,Voyager Therapeutics Announces Publication Of Vectored Anti-Tau Monoclonal Antibody Study In The Journal Of Neuroscience
2017-01-20,Voyager Therapeutics Announces Updates From Phase 1b Trial Of VY-AADC01 For Advanced Parkinson's Disease
2017-01-05,Voyager Therapeutics Elects Wendy Dixon, Ph.D. And Glenn Pierce, M.D., Ph.D. To Board Of Directors
2017-01-03,Voyager Therapeutics Appoints Jane Pritchett Henderson As Chief Financial Officer
2016-12-13,Ratings Changes Today
2016-12-09,Voyager Therapeutics To Attend Upcoming Investor Conference
2016-12-07,Voyager Gene Therapy Shows Early, Promising Motor Function Improvements for Parkinson's Patients
2016-12-07,Voyager Therapeutics Announces Positive Interim Results From Phase 1b Trial Of VY-AADC01 For Advanced Parkinson's Disease
2016-11-29,Voyager Therapeutics And REGENXBIO Announce Exercise Of Options For Rights To NAV Vectors
2016-11-10,Voyager Therapeutics Provides Third Quarter 2016 Investor Update
2016-11-01,Voyager Therapeutics To Host Third Quarter 2016 Investor Update Call
2016-10-18,Voyager Therapeutics Announces Planned Transition Process For Chief Financial Officer
2016-09-29,Voyager Therapeutics is Now Oversold (VYGR)
2016-09-15,Voyager Therapeutics Licenses Novel Gene Therapy Capsids From The California Institute Of Technology
2016-09-12,Voyager Therapeutics And CHDI Foundation Collaborate To Develop Novel Gene Therapy For Huntington's Disease
2016-08-12,Voyager Therapeutics To Attend Upcoming Investor Conferences
2016-08-11,Voyager Therapeutics Provides Second Quarter 2016 Investor Update
2016-08-09,Voyager Therapeutics Initiates Third Cohort In Ongoing Phase 1b Clinical Trial Of VY-AADC01 In Advanced Parkinson's Disease
2016-08-04,Voyager Therapeutics To Host Second Quarter 2016 Investor Update Call
2016-06-22,Voyager Therapeutics Announces Interim Phase 1b Surgical Results For VY-AADC01 In Advanced Parkinson's Disease
2016-05-12,Voyager Therapeutics Provides First Quarter 2016 Investor Update
2016-05-11,Voyager Therapeutics To Present At Upcoming Investor Conferences
2016-05-05,Voyager Therapeutics To Host First Quarter 2016 Investor Update Call
2016-04-29,Voyager Therapeutics Highlights Programs In Parkinson's Disease And ALS; Announces Expansion Of CNS Pipeline At R&D Day
2016-04-14,Voyager Therapeutics To Host R&D Day And Webcast On April 29, 2016
2016-03-17,Voyager Therapeutics Provides Fourth Quarter And Full Year 2015 Investor Update
2016-03-14,Voyager Therapeutics To Present At Alliance For Regenerative Medicine's 4th Annual Cell & Gene Therapy Investor Day
2016-03-10,Voyager Therapeutics To Host Fourth Quarter And Full Year 2015 Investor Update Call
2016-02-29,Voyager Therapeutics To Present At Cowen And Company 36th Annual Health Care Conference
2016-02-04,Oversold Conditions For Voyager Therapeutics (VYGR)
2016-02-02,Voyager Therapeutics Promotes Jeff Goater To Chief Financial Officer
2015-12-18,Voyager Therapeutics Added To Russell 2000®, 3000® And Global Indexes
2015-12-17,Voyager Therapeutics Reports Third Quarter 2015 Financial Results
2015-11-16,Voyager Therapeutics Announces Closing Of Initial Public Offering, Including Full Exercise Of Option To Purchase Additional Shares
,
,
,
,
